Paul Hastings

Paul Hastings

DirectoratNkarta· In proxies 2022–2025

Pay in FY2025-25% from the year before · Nkarta stock -25.7% the same year

Paul Hastings was paid $3.0M in FY2025 (Dec), down 25%. Nkarta stock fell 25.7% that year.

Pay$100 in the stock at the end of FY21 → $12
Pay is from the Summary Compensation Table of each Nkarta proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. enGene TherapeuticsPublic company · 2 yr
    • Director2024 – Present · 2 yrNo stock prices for these years
  2. NkartaPublic company · 4 yr
    • Chief Executive Officer2022 – Present · 4 yrStock in role -89%
  3. Pacira BioSciencesPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  4. Biotechnology Innovation Organization (BIO), Chair of the Board and Chair EmeritusPublic company
    • Director? – PresentNo stock prices for these years
  5. Nkarta Therapeutics (Nasdaq: NKTX) OTHER CURRENT DIRECTORSHIPSPublic company
    • Director? – PresentNo stock prices for these years
  6. Specific BiologicsPublic company
    • Director? – PresentNo stock prices for these years
  7. ViaCyte, Inc.Public company
    • Director? – PresentNo stock prices for these years
  8. Proteon TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years
  9. Protara Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  10. Proteolix, Inc.Public company
    • Director? – PresentNo stock prices for these years
  11. RelypsaPublic company
    • Director? – PresentNo stock prices for these years
  12. ViaCell, Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Boards1

  • enGene TherapeuticsDirector · 1 yr on the boardIndependentNominating and Corporate Governance—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

Two people shown as one, or a wrong number?